Trial Profile
Effect of Candesarutan and Piogritazon in diabetic patients with hypertension
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Mar 2013
Price :
$35
*
At a glance
- Drugs Candesartan cilexetil (Primary) ; Pioglitazone (Primary)
- Indications Hypertension in diabetes
- Focus Biomarker; Pharmacodynamics
- 06 Mar 2013 New trial record